Lighthouse Financial Advisors’s Novavax NVAX Stock Holding History

Lighthouse Financial Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-91	Closed	–	–	199
2019 Q4	$0	Buy	+91	New	+$395	﹤0.01%	283

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lighthouse Financial Advisors's NVAX Position: Q1 2020 in Review

Lighthouse Financial Advisors sold out of Novavax (NVAX) in Q1 2020, closing a stake of 91 shares.

Lighthouse Financial Advisors first reported a position in NVAX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 117 funds tracked by Wall St. Rank hold NVAX as of Q1 2020.

Lighthouse Financial Advisors reported no remaining Novavax position as of Q1 2020 after selling out during the quarter.
Lighthouse Financial Advisors sold 91 Novavax shares in Q1 2020.
Lighthouse Financial Advisors first reported a position in Novavax in Q4 2019 and held it in 1 quarter.
Lighthouse Financial Advisors's Novavax position peaked at $0 in Q4 2019.
117 funds tracked by Wall St. Rank held Novavax as of Q1 2020.

Based on Lighthouse Financial Advisors's 13F filing for Q1 2020, filed 8 May 2020.